Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial

Introduction Ebola virus disease remains a significant public health concern. For protection from Ebola virus, the main target populations are epidemiologically identified and often include healthcare workers and refugees. These target populations are also routinely offered vaccines for other vaccin...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alice Packham, Yemisi Takwoingi, Christopher A Green, Julien Nyombayire, Jean Pierre Musabyimana, Claude Muvunyi, Karishma Gokani, Alice E Taylor, Hugor Shema, Ariane Mutabaruka, Siobhan Roche, Claudine Umuhoza
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-09-01
coleção:	BMJ Open
Acesso em linha:	https://bmjopen.bmj.com/content/15/9/e102898.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!